Rocket Pharmaceuticals (RCKT) EBITDA (2014 - 2026)
Rocket Pharmaceuticals (RCKT) posted EBITDA of -$45.36 million for Q2 2026, compared with -$69.11 million a year earlier.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) EBITDA (2014 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA at Rocket Pharmaceuticals was -$184.09 million; for FY2025, it came in at -$222.88 million.
- In prior years, Rocket Pharmaceuticals' EBITDA was -$265.98 million in FY2024, -$254.72 million in FY2023, -$220.41 million in FY2022 and -$164.01 million in FY2021.
- Quarterly EBITDA has run from a low of -$71.88 million in Q2 2024 to a high of -$41.76 million in Q1 2022 over five years.
- According to Business Quant data, EBITDA for the three prior quarters was -$46.9 million (Q1 2026), -$42.29 million (Q4 2025) and -$49.55 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 7.34 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 5.99 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Rocket Pharmaceuticals | 268.37 Mn | -15.33 Mn | - | -44.82 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -44.82 Mn |
| Mar 31, 2026 | -46.37 Mn |
| Dec 31, 2025 | -41.75 Mn |
| Sep 30, 2025 | -49.01 Mn |
| Jun 30, 2025 | -68.57 Mn |
| Mar 31, 2025 | -61.40 Mn |
| Dec 31, 2024 | -60.33 Mn |
| Sep 30, 2024 | -67.04 Mn |
| Jun 30, 2024 | -71.34 Mn |
| Mar 31, 2024 | -65.12 Mn |
| Dec 31, 2023 | -63.50 Mn |
| Sep 30, 2023 | -63.67 Mn |
| Jun 30, 2023 | -67.03 Mn |
| Mar 31, 2023 | -60.52 Mn |
| Dec 31, 2022 | -68.03 Mn |
| Sep 30, 2022 | -57.41 Mn |
| Jun 30, 2022 | -53.21 Mn |
| Mar 31, 2022 | -41.76 Mn |
| Dec 31, 2021 | -43.29 Mn |
| Sep 30, 2021 | -48.80 Mn |
API Access
Rocket Pharmaceuticals EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();